Position
Fidelity in Amylyx Pharmaceuticals, Inc.
Back to the book · All holders of AMLX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $67.5M$13.90 → $17.96
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 16.5M | $199.5M | — | — | — | 0.0% |
| Q1 2026 | 16.6M | $231.2M | $13.90 | $30.1M | $1.56M | 0.0% |
| Q2 2026 | 16.7M | $300.4M | $17.96 | $67.5M | $1.75M | 0.0% |